Probable valproate sodium-associated hypotension

American Journal Geriatric Pharmacotherapy

Volumn 8, Issue 3, 2010, Pages 281-284

  Ota, Ken S ^a  

^a Family Medicine Center   (United States)

Author keywords

Antiepileptic drug; Geriatric; Hypotension; Valproate

Indexed keywords

ACETYLSALICYLIC ACID; GLIBENCLAMIDE; PHENYTOIN; VALPROATE SEMISODIUM; VALPROIC ACID; ANTICONVULSIVE AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MAINTENANCE THERAPY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN ALLERGY; CHEMICALLY INDUCED DISORDER; EPILEPTIC STATE; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION;

AGED; ANTICONVULSANTS; FLUID THERAPY; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; STATUS EPILEPTICUS; VALPROIC ACID;

EID: 77955506337     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2010.04.005     Document Type: Article

References (11)

1. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial. J Child Neurol. 2007;22:1191-1197.
2. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-experience in 102 adult patients. Seizures. 2005;14:164-169. (Pubitemid 40425264)
3. Limdi NA, Knowlton RK, Cofield SS, et al. Safety of rapid intravenous loading of valproate. Epilepsia. 2007; 48:478-483. (Pubitemid 46365200)
4. Altuntaş Y, Oztürk B, Erdem L, et al. Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: Case report. South Med J. 2003;96:201-203. (Pubitemid 36268596)
5. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: Epidemiology and treatment options. Drugs Aging. 2001;18:133-142. (Pubitemid 32269587)
6. Limdi NA, Faught E. The safety of rapid valproic acid infusion. Epilepsia. 2000;41:1342-1345.
7. White JR, Santos CS. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus. J Child Neurol. 1999;14:822-823. (Pubitemid 30035510)
8. Kumar P, Vallis CJ, Hall CM. Intravenous valproate associated with circulatory collapse. Ann Pharmacother. 2003;37:1797-1799. (Pubitemid 37466574)
9. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. (Pubitemid 12149145)
10. Depacon (valproate sodium) [package insert]. McPherson, Kan: Hospira, Inc; 2009. http://www.rxabbott.com/pdf/depacon.pdf Accessed January 20, 2010.
11. Perucca E, Grimaldi R, Gatti G, et al. Pharmacokinetics of valproic acid in the elderly. Br J Clin Pharmacol. 1984;17:665-669. (Pubitemid 14068498)